ES8406546A1 - Preparacion del nuevo complejo antibiotico cp-55358. - Google Patents

Preparacion del nuevo complejo antibiotico cp-55358.

Info

Publication number
ES8406546A1
ES8406546A1 ES522064A ES522064A ES8406546A1 ES 8406546 A1 ES8406546 A1 ES 8406546A1 ES 522064 A ES522064 A ES 522064A ES 522064 A ES522064 A ES 522064A ES 8406546 A1 ES8406546 A1 ES 8406546A1
Authority
ES
Spain
Prior art keywords
chem
formula
streptomyces
macrolide antibiotics
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES522064A
Other languages
English (en)
Other versions
ES522064A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc filed Critical Pfizer Inc
Publication of ES8406546A1 publication Critical patent/ES8406546A1/es
Publication of ES522064A0 publication Critical patent/ES522064A0/es
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/44Preparation of O-glycosides, e.g. glucosides
    • C12P19/60Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin
    • C12P19/62Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin the hetero ring having eight or more ring members and only oxygen as ring hetero atoms, e.g. erythromycin, spiramycin, nystatin
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/465Streptomyces
    • C12R2001/47Streptomyces albus

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

PROCEDIMIENTO PARA LA OBTENCION DEL COMPLEJO ANTIBIOTICO CP-55358, CONSTITUIDO POR LOS COMPUESTOS DE FORMULAS (I) Y (II), EN LAS QUE R TIENE LA FORMULA (III) Y R LA FORMULA (IV), Y DE SUS SALES DE ADICION DE ACIDO FISIOLOGICAMENTE COMPATIBLES.CONSISTE EN EL CULTIVO DEL MICROORGANISMO STREPTOMYCES ALBUS SUBSP. INDICUS ATC39012, EN CONDICIONES AEROBIAS SUMERGIDAS, EN UN MEDIO NUTRIENTE ACUOSO QUE CONTIENE FUENTES ASIMILABLES DE CARBONO Y NITROGENO; SEGUIDO DE LA SEPARACION DEL COMPUESTO.ESTE COMPLEJO TIENE APLICACIONES FARMACOLOQICAS COMO AGENTE ANTIBACTERIANO.
ES522064A 1982-05-03 1983-05-03 Preparacion del nuevo complejo antibiotico cp-55358. Granted ES522064A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/374,223 US4411892A (en) 1982-05-03 1982-05-03 Tylosin macrolide antibiotics from streptomyces

Publications (2)

Publication Number Publication Date
ES8406546A1 true ES8406546A1 (es) 1984-07-16
ES522064A0 ES522064A0 (es) 1984-07-16

Family

ID=23475858

Family Applications (1)

Application Number Title Priority Date Filing Date
ES522064A Granted ES522064A0 (es) 1982-05-03 1983-05-03 Preparacion del nuevo complejo antibiotico cp-55358.

Country Status (10)

Country Link
US (1) US4411892A (es)
EP (1) EP0094176B1 (es)
JP (1) JPS58213795A (es)
AT (1) ATE15049T1 (es)
CA (1) CA1200516A (es)
DE (1) DE3360601D1 (es)
DK (1) DK194283A (es)
ES (1) ES522064A0 (es)
GR (1) GR78186B (es)
IE (1) IE54941B1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0335704B1 (en) * 1988-03-30 1993-09-29 James Baber Rowe Treatment of equine livestock
MX9308001A (es) * 1992-12-21 1994-08-31 Lilly Co Eli Premezcla para piensos de animales que contiene tilosina y procedimiento para su obtencion.

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4201843A (en) * 1975-08-01 1980-05-06 Sanraku Ocean Co., Ltd. Process for manufacturing tylosin derivatives
SE445739B (sv) * 1978-09-14 1986-07-14 Toyo Jozo Kk 3", 4"-diacyltylosinderivat
US4252898A (en) * 1979-05-23 1981-02-24 Eli Lilly And Company Antibiotics A6888C and A6888X
US4358584A (en) * 1979-05-23 1982-11-09 Eli Lilly And Company Antibiotics A6888C and A6888X
NL8004922A (nl) * 1979-09-19 1981-03-23 Toyo Jozo Kk Deformyltylosinederivaten.
US4366309A (en) * 1980-03-14 1982-12-28 Schering Corporation Derivatives of antibiotic AR-5 components
HU189519B (en) * 1980-07-24 1986-07-28 Eli Lilly And Co,Us Process for preparing 2'''-o-demethyl-macrocin derivatives

Also Published As

Publication number Publication date
DK194283D0 (da) 1983-05-02
JPS58213795A (ja) 1983-12-12
EP0094176B1 (en) 1985-08-21
JPS6127400B2 (es) 1986-06-25
DE3360601D1 (en) 1985-09-26
IE830990L (en) 1983-11-03
US4411892A (en) 1983-10-25
EP0094176A1 (en) 1983-11-16
IE54941B1 (en) 1990-03-28
ATE15049T1 (de) 1985-09-15
ES522064A0 (es) 1984-07-16
GR78186B (es) 1984-09-26
CA1200516A (en) 1986-02-11
DK194283A (da) 1983-11-04

Similar Documents

Publication Publication Date Title
AU544790B2 (en) Epimeric azahomoerythromycin a derivatives
JPS5592387A (en) Antibiotic substance tm-531
ES8406546A1 (es) Preparacion del nuevo complejo antibiotico cp-55358.
AU548292B2 (en) 3-3-demethyl derivatives of istamycin b series compounds
DE3379735D1 (en) Antibiotic a51568 factors a and b
PT81118A (en) Process for preparing novel antibiotics and pharmaceutical compositions therefrom
BG40817A3 (en) Method for preparation of macrolidic antibiotics
IE881937L (en) Preparation of antibiotic furmifungin
JPS5511541A (en) Novel antibiotics and their preparation
ES8506313A1 (es) Un procedimiento para la preparacion de nuevos derivados de 7-oxo-1-azabiciclo(3.2.0)hepteno.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20040601